Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q3 2024 Earnings Call Transcript November 8, 2024
Y-mAbs Therapeutics, Inc. reports earnings inline with expectations. Reported EPS is $-0.16 EPS, expectations were $-0.16.
Operator: Good morning, and welcome to Y-mAbs Therapeutics Inc. Third Quarter Conference Call for 2024. At this time, all participants are in a listen-only mode. Instruction for the question-and-answer session will follow the prepared remarks. As a reminder, today’s conference will...
